The INDIBA Group stands at the forefront of transformative medical technologies with a five-decade legacy centered around Radiofrequency, Laser devices, and regenerative medicine solutions. As a pioneer in the sectors of Aesthetics, Rehabilitation, Intimate Health, Veterinary, and Pharma, their unique 448 kHz frequency technology has significantly impacted treatment methodologies worldwide.
Recent strides in strategic integration have seen INDIBA absorb K-LASER, further propelling its global influence in medical research and treatment. This expansion echoes their commitment to innovation, targeting enhanced patient recovery and meeting the evolving demands of healthcare, notably for the aging population. Founded in 1973 in Spain, INDIBA’s sustained emphasis on regulatory compliance and operational excellence has bolstered its market presence.
With a notable Private Equity Round investment from Charme Capital Partners in 2021, INDIBA is in a transformative growth phase, poised to conquer new markets and evolve its treatment offerings globally.